Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00194675 · ClinicalTrials.gov registry record · Phase 4
TRADE-Testosterone Replacement and Dutasteride Effectiveness
A Phase 4 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 4
- Development phase
- 53
- Enrollment target
NCT00194675 is a Phase 4 study that has completed, run by University of Washington. The registered enrollment target is 53 participants.
The verdict
NCT00194675, a Phase 4 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 53 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine whether the combination of the male hormone testosterone \[T\] in gel form and the oral drug dutasteride \[D\], used to shrink large prostate glands can safely reduce the size of the prostate gland and symptoms of prostate enlargement (called benign prostatic hyperplasia \[BPH\]) compared to T treatment alone in men with low testosterone (called hypogonadism).
Interventions
- DRUG Dutasteride
- DRUG Testosterone gel
- DRUG Placebo dutasteride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2005-03 |
| Est. Completion | 2010-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00194675
The ClinicalTrials.gov registry entry for NCT00194675 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Dutasteride is the first listed.
NCT00194675 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00194675 about?
NCT00194675 is a clinical study titled "TRADE-Testosterone Replacement and Dutasteride Effectiveness". The purpose of this research study is to determine whether the combination of the male hormone testosterone \[T\] in gel form and the oral drug dutasteride \[D\], used to shrink large prostate glands can safely reduce the size of the prostate gland and symptoms of prostate enlargement (called benign...
What is the current status of trial NCT00194675?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 53 participants. The study started on 2005-03. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00194675?
The interventions under investigation include: Dutasteride (DRUG), Testosterone gel (DRUG), Placebo dutasteride (DRUG).
Who is sponsoring clinical trial NCT00194675?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.